An Iowa telepharmacy company faces allegations in a civil lawsuit that it sold counterfeit Ozempic, the high-demand weight-loss drug, to a Michigan company
Supplementation with the L-carnitine, alpha-lipoic acid combination reduced the level of ROS by 28 percent, compared to placebo
LiuKZhouRWangBChenKShiLYZhuJDet al
Animals that lack the GLP-1R do not show evidence of liraglutide in the ARC suggesting that peripherally administered liraglutide requires the GLP-1R to enter into the CNS (Secher et al., 2014)
meaning that animal studies have shown some adverse effect or there are no well-controlled studies in humans, but potential benefits may warrant use despite potential risks
Depending on the reason, the next move might be: Resubmitting with better documentation Trying a different covered medication Completing the required lifestyle program over the next 3 to 6 months Filing a formal appeal with new clinical evidence Switching to cash-pay or manufacturer programs Pausing the GLP-1 path and addressing an underlying mental health, hormonal, or metabolic issue first Considering a different FDA-approved weight loss medication The right next step depends on your specific plan, BMI, health history, prior medication trials, and treatment goals
